Life ScienceCompany
Global Cord Blood M&A Summary
Global Cord Blood has acquired 2 companies, including 2 in the last 5 years.
Global Cord Blood’s largest acquisition to date was in 2022, when it acquired Cellenkos for $664M. Global Cord Blood has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).
Global Cord Blood Business Overview
Where is Global Cord Blood headquartered?
Global Cord Blood is headquartered in Hong Kong, China.
What is Global Cord Blood’s revenue?
Global Cord Blood disclosed revenue of 1,243M CNY for 2022 and 1,160M CNY for 2021.
How many employees does Global Cord Blood have?
Global Cord Blood has 1,202 employees.
What sector is Global Cord Blood in?
Global Cord Blood is a life science company.
When was Global Cord Blood founded?
Global Cord Blood was founded in 2006.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 2
- Total Countries Invested 2